Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    14673054 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Promyelocytic Leukemia (M3);   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Recurrent Adult Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia
Intervention: Drug: selumetinib
2 Not yet recruiting Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
Conditions: Acute Myeloid Leukemia;   Elderly;   Intensive Chemotherapy Unfit
Intervention: Drug: Decitabine
3 Active, not recruiting Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Azacitidine;   Drug: Vorinostat
4 Completed A Pilot Study of ODSH in Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: PGX-ODSH-2013-AML-1

Study has passed its completion date and status has not been verified in more than two years.